CorMedix Inc.
corporate_fare Company Profile
CorMedix Inc. (NASDAQ:CRMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for CRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for CRMD spans 10-Q, 8-K, DEF 14A, PRE 14A.
Recent high-impact activity:
- CorMedix Q2 10-Q Reveals Material Weakness and $59M Letter of Credit
- CorMedix Backs FY26 Revenue Guidance of $325M-$345M
- CorMedix Q2 Revenue Jumps 157% to $101.9M, Raises Full-Year EBITDA Guidance
- CorMedix Derivative Suit Settled: Governance Reforms and a $3.9M Fee Request
- CorMedix Restructures Leadership, Appoints New COO & Commercial Officer
Financial Snapshot
Short Interest & Short Volume
18.49 days to coverFINRA reported short interest of 16,202,272 shares in CRMD as of the September 15, 2026 settlement, a 1.1% increase from the prior period — about 18.5 days to cover at its recent average daily volume. On October 2, 2026, 64.8% of CRMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.